The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000700336
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
10/04/2026
Date registered
Help: Date registered
11/06/2026
Date last updated
Help: Date last updated
11/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
11/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Evaluating the feasibility, acceptability and healthcare impact of a GP-integrated paediatric developmental clinic model for children aged 0–16 years in rural Western Australia
Scientific title
Evaluating the feasibility, acceptability and healthcare impact of a GP-integrated paediatric developmental clinic model for children aged 0–16 years in rural Western Australia
Additional trial identifiers [1] 317219 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Developmental delay 341936 0
Condition category
Condition code
Public Health 337579 337579 0 0
Health service research
Human Genetics and Inherited Disorders 337997 337997 0 0
Other human genetics and inherited disorders
Neurological 337998 337998 0 0
Other neurological disorders

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The intervention is a GP-integrated developmental and behavioural paediatric clinic model designed to improve access to assessment and care for children in rural and remote communities while awaiting specialist paediatrician review. The model is delivered by participating rural general practitioners (“Study GPs”) who receive targeted training in developmental and behavioural paediatrics, supported by specialist paediatricians and clinicians with expertise in developmental paediatrics, rural child health and developmental assessment, including administration of the Griffiths-III developmental assessment. For children aged over 6 years, developmental and behavioural assessment is undertaken by trained rural GPs with paediatrician support and case review, while children under 6 years are assessed by a rural general practitioner undertaking additional child health training (“RG-Paed”).

The intervention is delivered through a combination of face-to-face clinic appointments, telehealth-supported case conferencing, supervised clinical learning and multidisciplinary collaboration. Eligible families are invited to attend an individual assessment appointment with a participating Study GP while awaiting paediatrician review. Initial GP appointments are anticipated to last approximately 60–90 minutes depending on clinical complexity and available prior assessments. The assessment includes detailed developmental, behavioural, psychosocial and medical history-taking; review of prior medical and allied health reports; physical examination where indicated; identification of safeguarding or behavioural concerns; and preparation of a structured management summary for discussion with the supervising paediatrician. Paediatrician involvement occurs through existing outreach clinics and/or telehealth case conferencing with the GP.

The intervention is delivered within participating rural general practice and outreach paediatric clinic settings, with telehealth support provided through videoconference platforms including Teams and Zoom. Participating clinicians undertake approximately 10–20 hours of initial training delivered over several weeks prior to clinic commencement, followed by ongoing mentoring, supervision, case discussion and telehealth-supported learning throughout the study period to support fidelity to the intervention model and clinician skill development. Attendance at appointments and completion of assessment documentation and paediatric case discussions are monitored through clinic booking systems, attendance logs, and study records to assess adherence to the intervention.

Please note that the initial GP assessment will involve a comprehensive developmental and behavioural review conducted by a participating Study GP. This assessment will include collection of a detailed medical, developmental and psychosocial history; review of previous medical records and allied health reports; assessment of developmental concerns raised by carers, schools or other healthcare providers; physical examination where clinically indicated; and identification of any immediate health, behavioural or safeguarding concerns. The GP will document findings and prepare a structured summary and management plan for discussion with the supervising paediatrician.

Training will include education in paediatric developmental and behavioural assessment, developmental surveillance, neurodevelopmental conditions, structured history-taking, formulation of differential diagnoses, referral pathways, and multidisciplinary management planning. Participating clinicians will also undertake specific training in the administration and interpretation of developmental assessment tools including the Griffiths-III developmental assessment, as relevant to their clinical role.

The educational program will incorporate existing RACGP paediatric and child health educational resources, structured teaching sessions, supervised practical learning, and case discussion activities. Training will be delivered through a combination of online learning modules, videoconference teaching sessions (including Teams and Zoom), self-directed learning, and supervised clinical experience within developmental paediatric services
Intervention code [1] 333767 0
Early detection / Screening
Description of the comparator or control
The comparator for this study is the existing standard developmental and behavioural paediatric care pathway operating within the region prior to implementation of the GP-integrated clinic model for the preceding 6 month period of time using routine clinical documentation currently in use. Under the existing model, children referred with developmental and behavioural concerns are typically placed on waitlists for assessment by specialist paediatric services, with access dependent on outreach clinic availability, metropolitan referral pathways and limited regional specialist capacity. Comparator data will include historical models of paediatric developmental assessment and management, including referral pathways, service utilisation patterns and wait times for paediatric review within the region.

Care within the comparator model is delivered primarily by specialist paediatricians and existing allied health and child development services with expertise in developmental and behavioural paediatrics. Assessments are generally conducted through conventional specialist outpatient paediatric services, outreach clinics and hospital-based developmental clinics.

The comparator model is delivered predominantly through individual face-to-face paediatric outpatient appointments, with some services incorporating telehealth review where available. The frequency and duration of appointments vary according to clinical demand, service availability, and patient complexity. Initial developmental paediatric appointments within existing services are commonly scheduled as single specialist consultations, often lasting approximately 45–90 minutes, followed by additional review appointments and allied health assessments as required. Wait times for initial specialist review may extend over prolonged periods due to workforce shortages and limited regional developmental paediatric capacity.

Comparator services are delivered through existing regional outreach clinics, hospital outpatient departments, child development services and metropolitan tertiary paediatric centres servicing rural and remote patients. Attendance and adherence within the comparator arm will be assessed retrospectively using routinely collected health service data, including referral records, outpatient booking systems, clinic attendance data and documented wait times from referral to paediatric review. Monitoring will also include review of completed appointments, missed appointments, and time intervals between referral, assessment and initiation of management within existing care pathways.
Control group
Historical

Outcomes
Primary outcome [1] 345338 0
Concordance of assessments, including time to diagnosis and intervention, by research GP and paediatricians.
Timepoint [1] 345338 0
After paediatric consultation and review.
Primary outcome [2] 345339 0
To review carer confidence in healthcare provider including assessment of overall quality of treatment and care according to carer/consumer with an an additional assessment of cost.
Timepoint [2] 345339 0
At the end of PREM completion and consumer feedback process with cost analysis at the end of the study.
Secondary outcome [1] 460346 0
Time on paediatric developmental waitlist and management occurring, via allied health review, occurring prior to specialist paediatrician clinic review.
Timepoint [1] 460346 0
At the end of the study.
Secondary outcome [2] 461624 0
To review development assessment tools to inform health system requirements within the region. .
Timepoint [2] 461624 0
At the end of assessment.

Eligibility
Key inclusion criteria
General Practitioners: Four GPs, who have attended a pre-study paediatric developmental workshop run by a local paediatrician, will conduct the ‘over 6-year-old’ GP-integrated developmental clinics, completing the initial assessments ahead of formal specialist paediatrician review. The Study GPs will be identified through local professional networks.
Inclusion criteria:
• Fully qualified GP practicing in the study catchment area
• Special interest in Child Health
• Attended pre-study workshop on paediatric development by local paediatrician

The Rural Generalist undertaking additional training in child health (RG-Paed): An RG-Paed (PI Mizzi) will undertake the additional training required to perform developmental assessments (Bayley-4 and Griffiths-III) under the supervision of a specialist paediatrician. The participating RG-Paed will conduct the ‘under 6-year-old’ GP-integrated developmental clinics, completing the initial assessments ahead of formal paediatric specialist review.
Inclusion criteria:
• Fully qualified GP practicing in the study catchment area
• Trained in Bayleys-4 and / or Griffiths-III developmental assessment tools
• Enrolled or completed further postgraduate paediatric training
Children to be assessed:
Any patient from the Warren/Blackwood region waitlisted for developmental assessment during the study period will be eligible to participate in the GP-integrated model of care pilot. Children of carers who do not consent to their participation will remain on the waitlist to see the paediatrician in the usual timeframe without any impact on care provided.
Inclusion criteria:
• Age 0-16 years
• Currently waitlisted for specialist paediatric developmental assessment
• Resident of Warren/Blackwood region
• Informed consent provided by carer.
Exclusion criteria:
• Patient already undergone formal paediatric assessment for current concerns
• Informed consent not provided by carer
• Not resident in Warren / Blackwood region
• Children in the care of the State

Specialist paediatricians:
Specialist paediatricians whose normal role includes developmental assessments in association with CDS in the South West region. The paediatricians will be provided with the preliminary report by the Study GPs ahead of their consultation with the patient. Consultations in the under 6-year-old clinic will be face-to-face with the paediatrician in the Warren region, whereas specialist consultations for the over 6-year-old clinics (Part A only) may be via telehealth in conference with the assessing GP present (paediatrician located in Bunbury, patient and GP located Warren/Blackwood).
Inclusion criteria:
• Specialist paediatrician
• Existing role as a clinician conducting developmental assessments in association with CDS in the South West region
Minimum age
No limit
Maximum age
65 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Exclusion criteria:
• Patient already undergone formal paediatric assessment for current concerns
• Informed consent not provided by carer
• Not resident in Warren / Blackwood region
• Children in the care of the State

Study design
Purpose of the study
Diagnosis
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other
Other design features
As this is a non-randomised implementation study, participants will not be allocated through randomisation. Outcomes from participants assessed under the intervention model will be compared with a historical comparator cohort consisting of consecutive developmental paediatric assessments conducted during the six months prior to implementation of the intervention. Historical comparator data will be obtained through retrospective review of clinical records.
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
Data analysis:

Data from the under and over 6-year-old clinics will be analysed for clinic wait times, number of patients seen, and time taken per consultation. Further data will be obtained from the participating Study GPs, CDS and research team on project costings to provide an estimated cost per patient. Quantitative analysis of PREM results will provide information on acceptability of the GP-Integrated Model of care to carers.

Preliminary management plans considered safe will be those that:
• Were appropriately triaged for next follow-up;
• Involved consultation with the specialist paediatrician or other appropriate specialist, if required; and
• Included appropriate involvement from other members of the multi-disciplinary team.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
WA

Funding & Sponsors
Funding source category [1] 321604 0
Government body
Name [1] 321604 0
WA Country Health Service
Country [1] 321604 0
Australia
Primary sponsor type
Government body
Name
WA Country Health Service
Address
Country
Australia
Secondary sponsor category [1] 324648 0
None
Name [1] 324648 0
None
Address [1] 324648 0
Country [1] 324648 0
Other collaborator category [1] 283900 0
University
Name [1] 283900 0
Rural Clinical School of Western Australia
Address [1] 283900 0
Country [1] 283900 0
Australia
Other collaborator category [2] 283901 0
Hospital
Name [2] 283901 0
WA Country Health Service: Bunbury Paediatrics team, Child Development Services
Address [2] 283901 0
Country [2] 283901 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320130 0
Child and Adolescent Health Service Human Research Ethics Committee
Ethics committee address [1] 320130 0
Ethics committee country [1] 320130 0
Australia
Date submitted for ethics approval [1] 320130 0
10/10/2024
Approval date [1] 320130 0
27/11/2024
Ethics approval number [1] 320130 0
RGS0000006629

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149534 0
Dr Kayla Mizzi
Address 149534 0
Warren Health Service, PO Box 272, Bunbury, WA, 6231
Country 149534 0
Australia
Phone 149534 0
+61 448 478 623
Fax 149534 0
Email 149534 0
Contact person for public queries
Name 149535 0
Bradley MacDonald
Address 149535 0
RCSWA, 76 Gale Street, Busselton WA 6280
Country 149535 0
Australia
Phone 149535 0
+61 423527399
Fax 149535 0
Email 149535 0
Contact person for scientific queries
Name 149536 0
Kayla Mizzi
Address 149536 0
Warren Health Service, PO Box 272, Bunbury, WA, 6231
Country 149536 0
Australia
Phone 149536 0
+61 448 478 623
Fax 149536 0
Email 149536 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.